443 PARP is expressed in all subtypes of early breast cancer and is a predictive factor for response to neoadjuvant chemotherapy
G. von Minckwitz, B. Müller, S. Loibl, J.U. Blohmer, A. duBois, J. Huober, R. Kandolf, J. Budczies, C. DenkertVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70464-x
File:
PDF, 47 KB
english, 2010